Not applicableStudy completedNCT04537598What this trial is testingErector Spinae Plane Block for Post-nephrectomy PainWho this might be right forPain, Postoperative National Cancer Institute, Egypt 60
Not applicableNot Yet RecruitingNCT07285538What this trial is testingStereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal CancerWho this might be right forRenal CancerRenal Secondary CancerStereotactic Body Radiotherapy IRCCS San Raffaele 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487What this trial is testingNDI 1150-101 in Patients With Solid TumorsWho this might be right forSolid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more Nimbus Saturn, Inc. 106
Testing effectiveness (Phase 2)Ended earlyNCT00485563What this trial is testingA Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Endocyte 12
Not applicableStudy completedNCT01404104What this trial is testingNeo-adjuvant Temsirolimus in Patients With Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma St. Joseph's Healthcare Hamilton 11
Testing effectiveness (Phase 2)Study completedNCT01566747What this trial is testingSecond-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5Who this might be right forRenal Cell Carcinoma Cancer Trials Ireland 43
Large-scale testing (Phase 3)Ended earlyNCT03408652What this trial is testingEfficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted TherapiesWho this might be right forMetastatic Renal Cell Carcinoma Centre Leon Berard 1
Early research (Phase 1)Not Yet RecruitingNCT07500805What this trial is testingUCL70805F in Patients With CD70-positive Advanced Renal Clear Cell CarcinomaWho this might be right forCD70-positive Advanced Renal Clear Cell Carcinoma UTC Therapeutics Inc. 21
Testing effectiveness (Phase 2)UnknownNCT05124431What this trial is testingAnlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Fudan University 30
Not applicableUnknownNCT05005195What this trial is testingYorkshire Kidney Screening TrialWho this might be right forRenal Cell Carcinoma University of Leeds 5,850
Very early researchStudy completedNCT03071328What this trial is testingINJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological CancersWho this might be right forMetastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Urothelial CarcinomaMetastatic Renal Cell Carcinoma Duke University 10
Testing effectiveness (Phase 2)Ended earlyNCT02959554What this trial is testingStudy in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease ControlWho this might be right forMetastatic Renal Cell Carcinoma AIO-Studien-gGmbH 49
Testing effectiveness (Phase 2)Looking for participantsNCT07516366What this trial is testingTesting the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT TrialWho this might be right forClear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8Stage III Renal Cell Cancer AJCC v8+1 more National Cancer Institute (NCI) 16
Early research (Phase 1)Looking for participantsNCT06673329What this trial is testingBrodalumab in the Treatment of Immune-Related Adverse EventsWho this might be right forBreast CancerEsophageal CancerKidney Cancer+15 more Brian Henick, MD 11
Testing effectiveness (Phase 2)Study completedNCT03450057What this trial is testingEfficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal ImpairmentWho this might be right forRelapsed/Refractory Multiple Myeloma Hellenic Society of Hematology 38
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219What this trial is testingStudy of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Exelixis 855
Early research (Phase 1)Looking for participantsNCT06399419What this trial is testingCBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more Osel, Inc. 28
Early research (Phase 1)Study completedNCT01218854What this trial is testingA Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue BiopsyWho this might be right forLung NeoplasmsLiver NeoplasmsKidney Neoplasms+1 more National Institutes of Health Clinical Center (CC) 17
Not applicableWithdrawnNCT06554730What this trial is testingMSD Belzutifan PASWho this might be right forVon Hippel Lindau Disease Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Looking for participantsNCT07167329What this trial is testingReal-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL TrialWho this might be right forVon Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more José Claudio Casali da Rocha 100